The Role of Pharmacokinetics and Pharmacodynamics in Early Drug Development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - Roscovitine

Journal Title: Sultan Qaboos University Medical Journal - Year 2011, Vol 11, Issue 2

Abstract

Pharmacokinetics, pharmacodynamics and pharmacogenetics play an important role in drug discovery and contribute to treatment success. Tis is an essential issue in cancer treatment due to its high toxicity. During the last decade, cyclin-dependent kinase inhibitors were recognised as a new class of compounds that was introduced for the treatment of several diseases including cancer. Cyclin-dependent kinases (Cdks) play a key role in the regulation of cell cycle progression and ribonucleic acid transcription. Deregulation of Cdks has been associated with several malignancies, neurodegenerative disorders, viral and protozoa infections, glomerulonephritis and inflammatory diseases. (R)-roscovitine is a synthetic tri-substituted purine that inhibits selectively Cdk1, 2, 5, 7 and 9. Roscovitine has shown promising cytotoxicity in cell lines and tumor xenografts. In this paper, we present several aspects of pharmacokinetics (PK) and pharmacodynamics (PD) of roscovitine. We present also some of our investigations including bioanalysis, haematotoxicity, age dependent kinetics, PK and effects on Cdks in the brain. Unfavourable kinetic parameters in combination with poor distribution to the bone marrow compartment could explain the absence of myelosuppression in vivo despite the efcacy in vitro.Higher plasma and brain exposure and longer elimination half-life found in rat pups compared to adult rats may indicate that roscovitine can be a potential candidate for the treatment of brain tumours in children. Cdk5 inhibition and Erk1/2 activation that was detected in brain of rat pups may suggest the use of roscovitine in neurodegenerative diseases. Early pharmacokinetic/pharmacodynamic studies are important issues in drug discovery and may affect further development of promising drug candidates.

Authors and Affiliations

Moustapha Hassan| Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, Clinical Research Centrum, Karolinska University Hospital, Huddinge, Stockholm, Sweden, Hatem Sallam| Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, Zuzana Hassan| Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, Clinical Research Centrum, Karolinska University Hospital, Huddinge, Stockholm, Sweden

Keywords

Related Articles

Surgical Technique for Retroperitoneoscopic Nephrectomy A case report

A case of right non-functioning kidney secondary to chronic pyelonephritis is presented. Te successful management through retroperitoneoscopic nephrectomy is described, emphasising the technique of this minimally invas...

Cost-Effectiveness of Wound Care: A concept analysis

This review aimed to analyse the concept of cost-effectiveness within the context of chronic wound care using Walker and Avant’s approach. The Cumulative Index to Nursing and Allied Health Literature® (EBSCO Information...

Prevalence of asthma symptoms in Omani schoolchildren

Objectives: To determine the prevalence of asthma in Omani schoolchildren using the International Study of Asthma and Allergies in Children (ISAAC) protocols. Method: The ISAAC-written questionnaire was completed by a to...

Ovarian Vein Trombophlebitis An unusual cause of postpartum fever and abdominal pain

Ovarian vein thrombophlebitis is an uncommon, but potentially serious, complication of complicated deliveries. Prolonged rupture of membranes prior to delivery is a pre-disposing factor. We report a case of a patient wit...

Download PDF file
  • EP ID EP14040
  • DOI -
  • Views 322
  • Downloads 9

How To Cite

Moustapha Hassan, Hatem Sallam, Zuzana Hassan (2011). The Role of Pharmacokinetics and Pharmacodynamics in Early Drug Development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - Roscovitine. Sultan Qaboos University Medical Journal, 11(2), 165-178. https://europub.co.uk/articles/-A-14040